AG
XBI icon

Advisor Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Advisor Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.89M Sell
30,401
-1,840
-6% -$159K 0.02% 645
2019
Q3 		$2.46M Sell
32,241
-10,045
-24% -$835K 0.02% 674
2019
Q2 		$3.71M Sell
42,286
-17,082
-29% -$1.46M 0.03% 509
2019
Q1 		$5.38M Buy
59,368
+21,395
+56% +$1.82M 0.04% 357
2018
Q4 		$2.73M Sell
37,973
-213
-0.6% -$17.2K 0.03% 511
2018
Q3 		$3.66M Sell
38,186
-2,925
-7% -$284K 0.04% 428
2018
Q2 		$3.92M Buy
41,111
+1,058
+3% +$97.2K 0.05% 314
2018
Q1 		$3.52M Sell
40,053
-5,271
-12% -$481K 0.05% 351
2017
Q4 		$3.85M Buy
45,324
+11,213
+33% +$939K 0.05% 333
2017
Q3 		$2.95M Buy
34,111
+2,871
+9% +$230K 0.05% 364
2017
Q2 		$2.41M Sell
31,240
-26,555
-46% -$1.88M 0.04% 423
2017
Q1 		$4.01M Buy
57,795
+34,710
+150% +$2.33M 0.08% 256
2016
Q4 		$1.37M Sell
23,085
-724
-3% -$44.7K 0.03% 542
2016
Q3 		$1.58M Buy
23,809
+1,223
+5% +$75.7K 0.04% 479
2016
Q2 		$1.22M Buy
+22,586
New +$1.24M 0.03% 546

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Advisor Group's XBI Position: Q4 2019 in Review

Advisor Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.7% in Q4 2019, selling an estimated $159K and leaving 30,401 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #645.

Advisor Group first reported a position in XBI in Q2 2016 and has held it in 15 quarters since. The position peaked at $5.38M in Q1 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

  • Advisor Group held 30,401 shares of State Street SPDR S&P Biotech ETF worth $2.89M as of Q4 2019.
  • Advisor Group sold 1,840 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $159K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Advisor Group's portfolio in Q4 2019, its #645 holding.
  • Advisor Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's State Street SPDR S&P Biotech ETF position peaked at $5.38M in Q1 2019.
  • 474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.